NEW YORK, April 16, 2014 /PRNewswire/ -- Verde Media Group, Inc. (OTCBB: VMGI) has recently expanded its scope of operations beyond its Entertainment Division by creating a Biotech Division and made a number of announcements addressing the legalized cannabis market opportunity.
Legalized cannabis could easily be a multi-billion dollar revenue opportunity over the next several years and VMGI has positioned to participate in the upcoming boom. The Company's technology division, VMBD, will develop platform technologies for extracting highly purified forms of cannabis-based phytocannabinoids products, including D9 tetrahydrocannabinol (THC) and cannabidiol (CBD). VMBD will develop the derivative and ester forms of THC for increased potency and their use in different delivery systems, including sublingual, inhaled dosage forms and blending with food products.
An analyst report which details key attributes of the technologies, an overview of the company and analyst recommendation can be viewed in its entirety by using the link below. There is no cost required to view this report:
Copy and paste to browser may be required.
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is written and authored by Michael Andereg, CFA. An outsourced research services provider represented by Michael Andereg, CFA, provided Small Cap Specialists, LLC this article or report. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. Small Cap Specialists, LLC is not entitled to veto, interfere or alter the articles, documents or report once created and reviewed by the outsourced research provider represented by Michael Andereg, CFA.
If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at email@example.com. For any urgent concerns or inquiries, please contact us at firstname.lastname@example.org.
NO WARRANTY OR LIABILITY ASSUMED
Small Cap Specialists, LLC is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. Small Cap Specialists, LLC does not hold any positions in VMGI. No liability is accepted by Small Cap Specialists, LLC whatsoever for any direct, indirect or consequential loss arising from the use of this document. Small Cap Specialists, LLC expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Small Cap Specialists, LLC does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
Michael Andereg, CFA, is the author of research report. Information in this release is fact checked and produced on a best efforts basis by Michael Andereg, CFA.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Small Cap Specialists, LLC